Abstract

Colon cancer is the second leading cause of cancer death in the United States. Krüppel-like factor 4 (KLF4) is a transcription factor involved in both proliferation and differentiation in the colon. It is down-regulated in both mouse and human colonic adenomas and has been implicated as a tumor suppressor in the gut, whereas in breast cancer, KLF4 is an oncogene. KLF4 is also involved in reprogramming differentiated cells into pluripotent stem cells. KLF4 can act as a transcriptional activator or repressor, but the underlying mechanisms are poorly understood. We found that p300, a CREB-binding protein-related protein, interacts with KLF4 both in vitro and in vivo and activates transcription. We further made the novel observation that endogenous KLF4 is acetylated by p300/CBP in vivo and that mutations of the acetylated lysines resulted in a decreased ability of KLF4 to activate target genes, suggesting that acetylation is important for KLF4-mediated transactivation. Furthermore, we found that KLF4 differentially modulates histone H4 acetylation at the promoters of target genes. Co-transfection of KLF4 and HDAC3 resulted in a synergistic repression of a cyclin B(1) reporter construct. Our results suggest that KLF4 might function as an activator or repressor of transcription depending on whether it interacts with co-activators such as p300 and CREB-binding protein or co-repressors such as HDAC3.

Highlights

  • Fewer goblet cells, and the remaining goblet cells are histologically and ultrastructurally abnormal [7]

  • Expression of p21Cip1/WAF1 increased in a similar manner, whereas expression of cyclin B1 was strongly down-regulated at 48 h, suggesting that Kruppel-like factor 4 (KLF4) represses the cell cycle by differentially regulating expression of these genes

  • We made the novel observation KLF4 interacts with, and is acetylated by, the histone acetyltransferase (HAT) proteins p300 and CREB-binding protein (CBP). This observation is physiologically relevant, as we found that KLF4 is acetylated in vivo as well

Read more

Summary

EXPERIMENTAL PROCEDURES

Plasmid DNA Constructs—pCS2-KLF4 (N-terminal FLAG tag), FLAG-p300, and pRC-CMV-mCBP-HA have been described previously [14, 42,43,44]. GST beads containing purified GST or GST-p300 (CH3 domain) proteins were incubated with cell lysate containing FLAG-tagged KLF4 or KLF4 mutants at 4 °C overnight, and beads were washed three times with lysis buffer and boiled in 1ϫ SDS sample buffer, followed by analysis via Western blot. HEK293T cells were transiently transfected in a 12-well plate with 0.2 ␮g of the appropriate reporter and 0.5 ␮g of empty vector (pCS2ϩ) or the appropriate KLF4 construct with or without 0.5 ␮g of p300 plasmid DNA. HT29 cells were harvested after treatment with 5 mM sodium butyrate, and 40 ␮l of cell lysate was incubated with 200 ␮l of p-nitrophenyl phosphate (Sigma, catalog number A3469) in a 96-well plate for 1–3 h. For ChIP assays, antibodies used include p300 (Santa Cruz Biotechnology, catalog number sc-584), HDAC3 (BD Biosciences, catalog number 611124), and KLF4 [14]

RESULTS
Similar results were found with
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call